Login / Signup

Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea.

Hyeon Jeong LeeSonghee ChoJungeun ParkYan JinHyung Min KimDonghyun Jee
Published in: BMC health services research (2023)
In our study, the anti-VEGF injection for PDR was cost-effective from the payer and societal perspectives.
Keyphrases
  • diabetic retinopathy
  • vascular endothelial growth factor
  • optical coherence tomography
  • endothelial cells
  • ultrasound guided